Analyst Ratings for Ikena Oncology, Inc. (INKA)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/4/2023 | H.C. Wainwright | N/A | New Coverage | Buy (N/A) |
N/A (N/A) |
10.42 (10.42) |
0% | Details |
| 5/5/2021 | Credit Suisse » Updated 5/13/2022 |
Judah Frommer | New Coverage | Outperform (N/A) |
20.00 (24.00) |
9.82 (10.42) |
6.11% | Details |
